Department of Orthopaedic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Aging (Albany NY). 2023 May 17;15(10):4288-4303. doi: 10.18632/aging.204729.
Intervertebral disc degeneration (IDD) is a complex phenomenon and a multifactorial degenerative disease that creates a heavy economic burden on health systems globally. Currently, there is no specific treatment proven to be effective in reversing and delaying the progression of IDD.
This study consisted of animal and cell culture experiments. The role of DNA methyltransferase 1 (DNMT1) on regulating the M1/M2 macrophages polarization and pyroptosis, as well as its effect on Sirtuin 6 (SIRT6) expression in an IDD rat model and in tert-butyl hydroperoxide (TBHP)-treated nucleus pulposus cells (NPCs) were explored. Rat models were constructed, followed by transfection with lentiviral vector to inhibit DNMT1 or overexpress SIRT6. The NPCs were treated with THP-1-cells conditioned medium, and their pyroptosis, apoptosis, and viability were evaluated. Western blot, histological and immunohistochemistry staining, ELISA, PCR, and flow cytometry were all used to evaluate the role of DNMT1/ SIRT6 on macrophage polarization.
Silencing DNMT1 inhibited apoptosis, the expression of related inflammatory mediators (e.g., iNOS) and inflammatory cytokines (e.g., IL6 and TNF-α). Moreover, silencing DNMT1 significantly inhibited the expression of pyroptosis markers IL- 1β, IL-6, and IL-18 and decreased the NLRP3, ASC, and caspase-1 expression. On the other hand, M2 macrophage specific markers CD163, Arg-1, and MR were overexpressed upon silencing DNMT1 or SIRT6 overexpression. At the same time, silencing DNMT1 exerted a regulatory effect on increasing the SIRT6 expression.
DNMT1 may be a promising potential target for IDD treatment due to its ability to ameliorate the progression of the disease.
椎间盘退行性变(IDD)是一种复杂的现象,是一种多因素的退行性疾病,给全球的卫生系统带来了沉重的经济负担。目前,还没有被证实能有效逆转和延缓 IDD 进展的特定治疗方法。
本研究包括动物和细胞培养实验。探讨了 DNA 甲基转移酶 1(DNMT1)在调节 M1/M2 巨噬细胞极化和细胞焦亡,以及在 IDD 大鼠模型和 tert-butyl hydroperoxide(TBHP)处理的核髓核细胞(NPC)中对 Sirtuin 6(SIRT6)表达的作用。构建大鼠模型,然后用慢病毒载体转染抑制 DNMT1 或过表达 SIRT6。用 THP-1 细胞条件培养基处理 NPC,并评估其细胞焦亡、细胞凋亡和细胞活力。Western blot、组织学和免疫组织化学染色、ELISA、PCR 和流式细胞术均用于评估 DNMT1/SIRT6 对巨噬细胞极化的作用。
沉默 DNMT1 抑制了细胞凋亡、相关炎症介质(如 iNOS)和炎症细胞因子(如 IL6 和 TNF-α)的表达。此外,沉默 DNMT1 显著抑制了细胞焦亡标志物 IL-1β、IL-6 和 IL-18 的表达,并降低了 NLRP3、ASC 和 caspase-1 的表达。另一方面,沉默 DNMT1 或过表达 SIRT6 可过表达 M2 巨噬细胞特异性标志物 CD163、Arg-1 和 MR。同时,沉默 DNMT1 对增加 SIRT6 表达具有调节作用。
DNMT1 可能是治疗 IDD 的一个有前途的潜在靶点,因为它可以改善疾病的进展。